Altered Kir and gap junction channels in temporal lobe epilepsy

Altered Kir and gap junction channels in temporal lobe epilepsy

Neurochemistry International 63 (2013) 682–687 Contents lists available at SciVerse ScienceDirect Neurochemistry International journal homepage: www...

650KB Sizes 1 Downloads 111 Views

Neurochemistry International 63 (2013) 682–687

Contents lists available at SciVerse ScienceDirect

Neurochemistry International journal homepage: www.elsevier.com/locate/nci

Review

Altered Kir and gap junction channels in temporal lobe epilepsy Peter Bedner, Christian Steinhäuser ⇑ Institute of Cellular Neurosciences, University of Bonn, Bonn, Germany

a r t i c l e

i n f o

Article history: Available online 26 January 2013 Keywords: Epilepsy Astrocyte Kir4.1 Cx43 Cx30 Dye coupling

a b s t r a c t Since astrocytes may sense and respond to neuronal activity these cells are now considered important players in brain signaling. Astrocytes form large gap junction coupled syncytia allowing them to clear the extracellular space from K+ and neurotransmitters accumulating during neuronal activity, and redistribute it to sites of lower extracellular concentrations. Increasing evidence suggests a crucial role for dysfunctional astrocytes in the etiology of epilepsy. Notably, alterations in expression, localization and function of astroglial K+ channels as well as impaired K+ buffering was observed in specimens from patients with pharmacoresistant temporal lobe epilepsy and in chronic epilepsy models. Altered astroglial gap junction coupling has also been reported in epileptic tissue which, however, seems to play a dual role: (i) junctional coupling counteracts hyperactivity by facilitating clearance of elevated extracellular K+ and glutamate while (ii) it also provides a pathway for energetic substrates and fuels neuronal activity. Dysfunctional astrocytes should be considered promising targets for new therapeutic strategies. Ó 2013 Elsevier Ltd. All rights reserved.

1. Introduction Epilepsy is a condition of the brain characterized by the unpredictable occurrence of seizures, and despite medication about one third of patients have poor seizure control and become medically refractory. Many antiepileptic drugs (AEDs) must be taken chronically for seizure suppression, which often leads to unwanted side effects. Thus, there is an urgent need for the development of more specific AEDs. Recent critical reviews state the little progress AED development has made over the past years, and call for new concepts and fresh thinking to identify new targets for improved treatment of epilepsy (Löscher and Schmidt, 2011; Simonato et al., 2012). Still, epilepsy research is neuron-centered, which might be part of the dilemma because many of the alterations neurons undergo in the course of epilepsy seem to be secondary rather than causative for the epileptic condition. Astrocytes have now been recognized as active partners in neural information processing. These cells express a plethora of ion channels and transmitter receptors (Verkhratsky and Steinhäuser, 2000) which allow them to sense neuronal activity and feed back to neurons to modulate CNS signaling (Halassa and Haydon, 2010; Perea and Araque, 2010). While the pathways enabling activation of these cells under physiological conditions are still matter of investigation, evidence is emerging suggesting a critical role of

⇑ Corresponding author. Address: Institute of Cellular Neurosciences, Medical Faculty, University of Bonn, Sigmund Freud Str. 25, 53105 Bonn, Germany. Tel.: +49 228 287 14669; fax: +49 228 287 19121. E-mail addresses: [email protected] (P. Bedner), [email protected] (C. Steinhäuser). 0197-0186/$ - see front matter Ó 2013 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.neuint.2013.01.011

astrocyte dysfunction in the pathogenesis of neurological disorders (Seifert et al., 2006), including epilepsy (Seifert et al., 2010). In this review, we will focus on astroglial alterations in inwardly rectifying K+ (Kir) channels and gap junction coupling in temporal lobe epilepsy. The published data suggest that these changes might be causative for hyperexcitation, neurotoxicity and the generation or spread of seizure activity, and that astrocytes might represent promising new targets in the search for improved antiepileptic therapies. 2. Kir channels and temporal lobe epilepsy 2.1. K+ uptake and K+ spatial buffering Prolonged neuronal activity causes transient accumulation of extracellular K+ ([K+]o) which, if uncompensated, would lead to neuronal depolarization and consequently to hyperexcitability. During epileptiform activity, [K+]o can increase from the resting concentration of 3 mM to a ceiling level of 10–12 mM (Heinemann and Lux, 1977). Higher [K+]o concentrations (up to 60 mM) are observed under conditions such as hypoxia/ischemia and during spreading depression (Hansen, 1985; Somjen, 2001). Since even small changes in [K+]o can influence neuronal excitability, K+ homeostasis in the brain needs to be tightly regulated. Key players in this regulation are astrocytes whose membranes are highly permeable for K+ at resting potential and which are connected to each other via gap junction (GJ) channels to form a functional syncytium. During neuronal activity K+ buffering has been proposed to be realized by two different mechanisms: K+ uptake and spatial K+ buffering (for review see (Kofuji and Newman, 2004). Net

P. Bedner, C. Steinhäuser / Neurochemistry International 63 (2013) 682–687

uptake of K+ is mainly accomplished by glial and neuronal Na,KATPase and Na–K–Cl cotransporters (D’Ambrosio et al., 2002; Kofuji and Newman, 2004; Ransom et al., 2000). On the other hand, glial Kir channels in concert with Cl channels might contribute to K+ clearance through its net uptake. Kir channels have a high open probability at resting potential and their conductance increases at high [K+]o (Ransom and Sontheimer, 1995). The membrane conductance of astrocytes is dominated by Kir4.1 channels (Seifert et al., 2009) and accordingly, astrocyte-specific deletion of Kir4.1 caused defective K+ clearance and seizures (see below), emphasizing their crucial role in the regulation of [K+]o (Djukic et al., 2007; Haj-Yasein et al., 2011). However, the relative contribution of Kir channels vs. Na–K pumps in net K+ uptake is still under debate (Kofuji and Newman, 2004; Olsen and Sontheimer, 2008; Walz, 2000). The model of spatial buffering, first described by (Orkand et al., 1966), implies that K+ taken up by astrocytes at sides of high neuronal activity is transported through the GJ connected astrocytic network to distal regions of lower [K+]o. This mechanism is energy-independent, driven by the local K+ equilibrium potential and the glial syncytium membrane potential (Kofuji and Newman, 2004; Orkand et al., 1966; Walz, 2000), and more efficient than diffusion through the extracellular space (Gardner-Medwin, 1983). To evaluate the importance of the glial syncytium for efficient buffering of K+, Wallraff et al. (2006) used K+-sensitive electrodes and assessed changes in [K+]o in hippocampal slices obtained from mice devoid of astrocytic GJ proteins (Cx30/; Cx43fl/fl hGFAP-Cre mice; termed dko mice). They found impaired spatial buffering in the stratum lacunosum-moleculare but, unexpectedly, preserved buffering in the stratum radiatum (Wallraff et al., 2006). Obviously GJ-independent mechanisms contribute to K+ buffering in the radiatum. In this context the concept of ‘indirect coupling’ has been suggested, which implies that the K+ released by one cell can be taken up by more distally located, non-coupled neighboring cells through K+ channels (Newman, 1995; Ransom, 1996). It is thought that in such a case, spatial buffer current may flow within single elongated astrocytes from sites of elevated [K+]o towards sites of lower [K+]o (Ransom, 1996; Wallraff et al., 2006). Such a process, termed ‘K+ siphoning’, has earlier been described within retinal Müller cells which transfer excess K+ from the inner plexiform layer to the vitreous humor and blood vessels (Newman et al., 1984). Besides K+ clearance, K+ siphoning was hypothesized to mediate neurovascular coupling (Paulson and Newman, 1987) which, however, could not be confirmed later on (Metea et al., 2007). In all forms of spatial buffering, the weakly-rectifying Kir4.1 channels which allow bidirectional diffusion of K+ across the membrane, may mediate not only uptake of K+ but also its release. 2.2. Kir4.1channels and K+ buffering in epilepsy To investigate the role of Kir4.1 channels in K+ buffering the effect of Ba2+, which at sub-mM concentrations selectively blocks Kir channels, on stimulus-induced rises in [K+]o or iontophoretically applied K+ was analyzed in sclerotic and non-sclerotic human hippocampal slices as well as in a rat model of epilepsy. It could be demonstrated that Ba2+ enhances [K+]o accumulation in non-sclerotic human and control rat hippocampus, but had no effect in sclerotic human and rat tissue. These results not only emphasized the importance of Kir4.1 channels in K+ buffering in the non-sclerotic hippocampus, but also provided evidence for the disturbance of Ba2+-sensitive K+-uptake in sclerosis (Heinemann et al., 2000; Jauch et al., 2002; Kivi et al., 2000). Consistent with this idea are the results from patch clamp studies performed in the human sclerotic CA1 region, demonstrating significantly reduced (Hinterkeuser et al., 2000; Schröder et al., 2000) or even complete loss (Bordey and Sontheimer, 1998) of Kir currents. In line with these reports,

683

Western blot analysis by (Das et al., 2012) revealed a 50% reduction of Kir4.1 protein levels in sclerotic human hippocampus compared to post-mortem control tissue. Taken together, these data strongly indicate that in TLE with hippocampal sclerosis, impaired K+ clearance and increased seizure susceptibility result from reduced expression of Kir channels. Whether these events represent the cause or the consequence of the disease is still an open question. (Takahashi et al., 2010) found no changes in astrocytic Kir currents 7–16 days following systemic injection of kainic acid in rats, which would indicate that Kir downregulation is a consequence of epilepsy. In contrast in an albumin model of epilepsy, downregulation of Kir4.1 was found to occur already before the onset of epileptic activity (David et al., 2009). Since blood–brain barrier lesion and the resulting extravasation of albumin are considered primary events in human epileptogenesis (Heinemann et al., 2012), the results by David et al. (2009) support a causative role for Kir channel downregulation in epilepsy. Genetic inactivation of the Kir4.1 encoding gene, KCNJ10, substantiated an essential role for Kir4.1 in glial K+ buffering (Djukic et al., 2007; Kofuji et al., 2000). General knock-out of Kir4.1 resulted in a severe pathology and lethality between postnatal days 8 and 24 (Neusch et al., 2001). Similarly, conditional knock-out mice with glia-specific deletion of Kir4.1 displayed a severe phenotype, including ataxia, seizures and early lethality (Djukic et al., 2007). In addition, the deletion caused substantial depolarization of gray matter astrocytes which not only impaired K+ buffering but also glutamate uptake. As a consequence, decreased spontaneous neuronal activity and enhanced synaptic potentiation was found in these mice (Djukic et al., 2007). The crucial role of Kir4.1 in K+ buffering has been confirmed in follow-up studies demonstrating that disruption of Kir4.1 expression causes an epileptic phenotype (Chever et al., 2010; Haj-Yasein et al., 2011). 2.3. KCNJ10 gene mutations cause epilepsy KCNJ10 is considered a potential causative candidate for increased seizure susceptibility (Ferraro et al., 2004). In children with seizures, ataxia, sensorineural deafness, mental retardation and electrolytic imbalance (SeSAME or EAST syndrome; (Bockenhauer et al., 2009; Scholl et al., 2009) sequencing of the affected KCNJ10 gene revealed various missense and nonsense mutations. These loss-of-function mutations of KCNJ10 were homozygous or compound heterozygous (Bockenhauer et al., 2009; Scholl et al., 2009). Heterologous expression confirmed that the mutations also affected Kir4.1 channel function, e.g. its Ba2+-sensitivity (Bockenhauer et al., 2009; Reichold et al., 2010; Williams et al., 2010). EAST/SeSAME syndrome-related mutations caused a decrease in K+ conductance, and the mutated Kir4.1 had a dominant negative effect when co-expressed with wildtype Kir4.1. Another group of epilepsy patients carried gain-of-function mutations of KCNJ10, and the afflicted patients presented with seizures, autism spectrum disorders and intellectual disability (Sicca et al., 2011). Single nucleotide variations in the KCNJ10 gene were detected in the DNA of TLE patients presenting with hippocampal sclerosis and antecedent febrile seizures. It was concluded that variations in AQP4 (encoding a water channel) and the KCNJ10/KCNJ9 region are likely to be associated with TLE and febrile seizures (Heuser et al., 2010). 3. GJ channels and temporal lobe epilepsy 3.1. Potential roles of GJs in epilepsy In the adult brain, hippocampal astrocytes express the GJ proteins connexin43 (Cx43) and connexin30 (Cx30) (Nagy and Rash, 2000). Consistently, mice lacking these two proteins were devoid

684

P. Bedner, C. Steinhäuser / Neurochemistry International 63 (2013) 682–687

of tracer coupling (Wallraff et al., 2006). The major astrocytic GJ protein in the hippocampus seems to be Cx43, since only a 22% reduction of interastrocytic coupling was observed in Cx30-deficient mice (Gosejacob et al., 2011). The role of the astroglial network in the pathophysiology of epilepsy is still controversial. A potential antiepileptic function is based on its ability to decrease neuronal excitability by clearance and redistribution of extracellular ions and neurotransmitter (Fig. 1). Disturbance of this function may cause accumulation of K+ and glutamate in the extracellular space (ECS) and, consequently, epileptic seizures. Moreover, disruption of interastrocytic communication was found to cause a reduction of the ECS volume due to astrocytic swelling, further increasing extracellular ion concentrations (Pannasch et al., 2011). Accordingly, disturbed K+ and glutamate clearance, astrocytic swelling, increased synaptic transmission as well as spontaneous epileptiform activity and a decreased threshold for evoking seizure activity have been described in mice with coupling-deficient astrocytes (Pannasch et al., 2011; Wallraff et al., 2006). While these results provide strong evidence for an anticonvulsive role of glial networks, a potential pro-epileptic function arose from findings of Rouach et al. (2008). These authors elegantly demonstrated that GJs are needed for the intercellular trafficking of glucose and its metabolites from

blood vessels through the astrocytic syncytium to distal neurons in an activity-dependent manner (Fig. 1). They proposed that this process is important to sustain synaptic activity under pathological conditions such as epilepsy (Rouach et al., 2008). Thus, reduction of astrocytic coupling seems to exert opposite effects on neuronal excitability: a rapid, seizure-promoting effect due to impaired K+ and glutamate redistribution, but a delayed, anticonvulsive effect because of insufficient energy supply. One could speculate that in this scenario, increased extracellular ion and neurotransmitter levels are responsible for seizure initiation while the disruption of neuronal energy supply terminates hyperactivity. In addition to interastrocytic coupling, panglial communication between astrocyte and oligodendrocytes through heterotypic GJs has been proposed to be involved in the regulation of K+ homeostasis. In this concept, K+ ions released during axonal activity are taken up by oligodendrocytes and transferred through reflexive GJs, which connect adjacent myelin layers of the same cell, to the cell body, and from there through heterotypic junctions into the astrocytic syncytium (Menichella et al., 2006; Rash, 2010). Disruption of this mechanism may result in inadequate K+ clearance and seizures. In accordance with this concept, mice lacking oligodendrocytic connexins (Cx32/ Cx47/ double KO) as well as mice in which panglial coupling is diminished (Cx30/ Cx47/ and

Fig. 1. Dual role of the astroglial syncytium in epilepsy. 1. Spatial K+ buffering. Neuronal activity causes transient elevations of [K+]o. The difference between the membrane potential and the K+ equilibrium potential causes K+ influx into nearby astrocytes. Intracellularly K+ propagates along the electrochemical gradient through the astroglial network and leaves at sites of lower [K+]o. 2. Spatial glutamate buffering. Glutamate released during synaptic activity is taken up astrocytes through the glutamate transporters GLAST and GLT-1. In astrocytes, glutamate is converted into glutamine by the enzyme glutamine synthetase (GS). Glutamine is then released into the ECS, taken up by neurons and reused for glutamate production. During high neuronal activity, dissipation of glutamate is facilitated by its diffusion through the gap junction connected astroglial syncytium. 3. Diffusion of energetic metabolites through the astroglial network sustains synaptic transmission. Glucose is taken up from the blood by astrocytes via the GLUT1 glucose transporter, metabolized to lactate and released into the ECS for neuronal use. Astrocytic gap junctional coupling mediates activity-dependent trafficking of glucose from blood vessels to the sites of high energy demand.

P. Bedner, C. Steinhäuser / Neurochemistry International 63 (2013) 682–687

Cx32/ Cx43/ double KO) display epileptic seizures (Maglione et al., 2010; Menichella et al., 2003, 2006; Tress et al., 2012). Thus, intercellular communication between astrocytes and oligodendrocytes and/or oligodendrocyte reflexive coupling may possess antiepileptic function. 3.2. GJ expression and communication in epileptic tissue Many studies have explored changes in connexin expression using a variety of animal models of seizures and human tissue, with conflicting results. In animals, increased, unchanged and decreased Cx mRNA and/or protein levels have been reported (Condorelli et al., 2002; Elisevich et al., 1997a, 1998; Gajda et al., 2003; Khurgel and Ivy, 1996; Li et al., 2001; Samoilova et al., 2003; Söhl et al., 2000; Szente et al., 2002; Takahashi et al., 2010; Xu et al., 2009). Differences between animal models and in seizure duration might account for this inconsistency. In human epileptic tissue resected from patients with intractable epilepsy, unchanged or elevated Cx43 mRNA and/or proteins levels were described (Aronica et al., 2001; Collignon et al., 2006; Das et al., 2012; Elisevich et al., 1997b; Fonseca et al., 2002; Naus et al., 1991). However, studies on human specimens have to be interpreted with caution because the tissue is usually obtained from patients with pharmacoresistant chronic epilepsy, raising the possibility that it is affected by the long-term treatment with AEDs. Furthermore, human studies suffer from the lack of appropriate controls. Generally, tumor or autopsy specimens were used as controls and it is possible that apparent increases in Cx levels in epileptic tissue are actually caused by decreased levels in controls (Nemani and Binder, 2005). In addition, Cx RNA or protein levels and the extent of functional coupling do not necessarily correlate, since posttranslational modifications, such as phosphorylation, may change gating properties, assembly or subcellular localization of the GJ channels. Functional analysis may therefore provide more accurate results. Increased interastrocytic communication has been described in a post-SE rat model of epilepsy (Takahashi et al., 2010) and in hippocampal slice cultures chronically exposed to bicuculline (Samoilova et al., 2003). Opposite results were reported by Xu et al. (2009), who observed reduced coupling in a mouse model of tuberous sclerosis complex. To our knowledge no functional coupling analyses have been performed in acute human epileptic slices so far. Using fluorescence recovery after photobleaching increased GJ coupling was found in astrocytes cultured from human epileptic specimens when compared with cultures from non-epileptic tissue (Lee et al., 1995). Another strategy to investigate the role of the astrocytic syncytium in epilepsy is pharmacological disruption of GJ communication using inhibitors (such as carbenoxolone, halothan and octanol), substances producing intracellular acidification (sodium propionate, carbon dioxide) or Cx mimetic peptides (small peptides mimicking a sequence of the connexin subunit, inhibiting GJ and Cx hemichannels by binding to their extracellular domain) (Bostanci and Bagirici, 2006, 2007; Gajda et al., 2003; Gigout et al., 2006; Jahromi et al., 2002; Kohling et al., 2001; Medina-Ceja et al., 2008; Perez-Velazquez et al., 1994; Ross et al., 2000; Samoilova et al., 2003, 2008; Szente et al., 2002; Voss et al., 2009). Most of these studies reported antiepileptic effects of GJ blockade although proepileptic effects have also been observed (Voss et al., 2009). In neocortical slices from patients with TLE or focal cortical dysplasia, GJ blockers inhibited spontaneous and evoked epileptiform activity, pointing to a proepileptic role of GJ coupling (Gigout et al., 2006). Here one has to consider that GJ blockers have usually dramatic side effects and barely discriminate between neuronal and glial GJs. In addition, pharmacological blockade may not only inhibit intercellular channels but also Cx and pannexin hemichannels (HCs) which possibly play a differential role in excitability.

685

3.3. Role of connexin hemichannels and pannexin channels in epilepsy There is abundant evidence that astrocytic connexins in addition to intercellular GJ channels also form functional membranespanning HCs (for review see (Saez et al., 2003; Theis and Giaume, 2012). These channels possess a low open probability under physiological conditions which, however, increases upon depolarization, altered Ca2+ concentrations, metabolic inhibition or cytokine activation (Giaume et al., 2010; Saez et al., 2005). Opened HCs are permeable for glutamate, ATP, glucose and glutathione (Cotrina et al., 2000; Rana and Dringen, 2007; Retamal et al., 2007; Ye et al., 2003). Elevated open probability of HCs may promote seizures due to excessive release of ATP and glutamate which in turn may increase synaptic excitability. Moreover, ATP release may facilitate the propagation of glial Ca2+ waves, leading to hypersynchronization and spread of ictal activity (Gomez-Gonzalo et al., 2010). It is also reasonable to assume that the role of HCs in epilepsy differs from that of GJ channels. Thus, inflammatory cytokines, which are overproduced in epileptic tissue (Avignone et al., 2008; Vezzani et al., 2012), decrease GJ coupling but increase the open probability of HCs (Meme et al., 2006; Retamal et al., 2007). Further support for this assumption came from the analysis of patients with oculodentodigital dysplasia (ODDD), a rare genetic disease which is caused by mutations in the gene encoding Cx43. Among other neurological symptoms these patients also developed seizures (Loddenkemper et al., 2002). In cell culture, some of the ODDD-associated mutations of Cx43 caused loss of GJ coupling, but increased HC activity (Dobrowolski et al., 2007). Moreover, (Yoon et al., 2010) showed that selective blockade of HCs by low doses of mimetic peptides had protective effects on seizure spread while inhibition of both HCs and GJs by high concentrations of the peptide exacerbated the lesions. Several recent studies questioned the functional significance of Cx HCs and suggest instead that another family of proteins, the pannexins (Panx), form functional non-junctional plasma membrane channels under physiological conditions (Scemes et al., 2009; Scemes and Spray, 2012). These channels are opened by increases in [K+]o, depolarization, cytosolic Ca2+ elevation, mechanical stress and P2X7 receptor activation and permeable for large molecules, such as ATP (Scemes and Spray, 2012; Suadicani et al., 2012). Since high neuronal activity entails increases in [K+]o it was suggested that the resulting opening of Panx might contribute to seizures, through release of ATP. Indeed, pharmacological blockade or deletion of Panx1 in transgenic mice attenuated seizure activity during kainic acid-induced status epilepticus (Santiago et al., 2011). In line with these findings, (Mylvaganam et al., 2010) reported increased Panx transcript levels in an in vitro seizure model.

4. Concluding remarks The new view of brain function considers astrocytes as communication partners of neurons. Accordingly, it is not surprising that increasing evidence suggests a role for these cells in epilepsy. Several laboratories reported dysfunction and dysregulation of astroglial Kir channels and gap junction networks in human and experimental epilepsy. These alterations entail impaired removal and redistribution of K+ and glutamate which are also key features of human TLE with sclerosis. Although in many cases it is still unclear whether the reported astroglial alterations are causative or a consequence of the condition, glial cells, and astrocytes in particular, emerge as new, promising targets for the development of improved AEDs. Future work will clarify whether TLE is a glial rather than a neuronal disorder and hopefully facilitate more specific therapeutic approaches to treat this condition.

686

P. Bedner, C. Steinhäuser / Neurochemistry International 63 (2013) 682–687

Acknowledgement Work of the authors is supported by Deutsche Forschungsgemeinschaft (SFB/TR3 C1, C9) and European Commission (FP7202167 NeuroGLIA).

References Aronica, E., Gorter, J.A., Jansen, G.H., Leenstra, S., Yankaya, B., Troost, D., 2001. Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsyassociated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol. (Berl) 101, 449–459. Avignone, E., Ulmann, L., Levavasseur, F., Rassendren, F., Audinat, E., 2008. Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J. Neurosci. 28, 9133–9144. Bockenhauer, D., Feather, S., Stanescu, H.C., Bandulik, S., Zdebik, A.A., Reichold, M., Tobin, J., Lieberer, E., Sterner, C., Landoure, G., Arora, R., Sirimanna, T., Thompson, D., Cross, J.H., van’t, H.W., Al, M.O., Tullus, K., Yeung, S., Anikster, Y., Klootwijk, E., Hubank, M., Dillon, M.J., Heitzmann, D., rcos-Burgos, M., Knepper, M.A., Dobbie, A., Gahl, W.A., Warth, R., Sheridan, E., Kleta, R., 2009. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N. Engl. J. Med. 360, 1960–1970. Bordey, A., Sontheimer, H., 1998. Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res. 32, 286–303. Bostanci, M.O., Bagirici, F., 2006. The effects of octanol on penicillin induced epileptiform activity in rats: an in vivo study. Epilepsy Res. 71, 188–194. Bostanci, M.O., Bagirici, F., 2007. Anticonvulsive effects of carbenoxolone on penicillin-induced epileptiform activity: an in vivo study. Neuropharmacology 52, 362–367. Chever, O., Djukic, B., McCarthy, K.D., Amzica, F., 2010. Implication of kir4.1 channel in excess potassium clearance. an in vivo study on anesthetized glialconditional kir4.1 knock-out mice. J. Neurosci. 30, 15769–15777. Collignon, F., Wetjen, N.M., Cohen-Gadol, A.A., Cascino, G.D., Parisi, J., Meyer, F.B., Marsh, W.R., Roche, P., Weigand, S.D., 2006. Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans. J. Neurosurg. 105, 77–87. Condorelli, D.F., Mudo, G., Trovato-Salinaro, A., Mirone, M.B., Amato, G., Belluardo, N., 2002. Connexin-30 mRNA is up-regulated in astrocytes and expressed in apoptotic neuronal cells of rat brain following kainate-induced seizures. Mol. Cell. Neurosci. 21, 94–113. Cotrina, M.L., Lin, J.H.C., López-García, J.C., Naus, C.C.G., Nedergaard, M., 2000. ATPmediated glia signaling. J. Neurosci. 20, 2835–2844. D’Ambrosio, R., Gordon, D.S., Winn, H.R., 2002. Differential role of KIR channel and Na(+)/K(+)-pump in the regulation of extracellular K(+) in rat hippocampus. J. Neurophysiol. 87, 87–102. Das, A., Wallace, G.C., Holmes, C., McDowell, M.L., Smith, J.A., Marshall, J.D., Bonilha, L., Edwards, J.C., Glazier, S.S., Ray, S.K., Banik, N.L., 2012. Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors. Neuroscience 220, 237–246. David, Y., Cacheaux, L.P., Ivens, S., Lapilover, E., Heinemann, U., Kaufer, D., Friedman, A., 2009. Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J. Neurosci. 29, 10588–10599. Djukic, B., Casper, K.B., Philpot, B.D., Chin, L.S., McCarthy, K.D., 2007. Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J. Neurosci. 27, 11354–11365. Dobrowolski, R., Sommershof, A., Willecke, K., 2007. Some oculodentodigital dysplasia-associated Cx43 mutations cause increased hemichannel activity in addition to deficient gap junction channels. J. Membr. Biol. 219, 9–17. Elisevich, K., Rempel, S.A., Smith, B., Allar, N., 1997a. Connexin 43 mRNA expression in two experimental models of epilepsy. Mol. Chem. Neuropathol. 32, 75–88. Elisevich, K., Rempel, S.A., Smith, B.J., Edvardsen, K., 1997b. Hippocampal connexin 43 expression in human complex partial seizure disorder. Exp. Neurol. 145, 154–164. Elisevich, K., Rempel, S.A., Smith, B., Hirst, K., 1998. Temporal profile of connexin 43 mRNA expression in a tetanus toxin-induced seizure disorder. Mol. Chem. Neuropathol. 35, 23–37. Ferraro, T.N., Golden, G.T., Smith, G.G., Martin, J.F., Lohoff, F.W., Gieringer, T.A., Zamboni, D., Schwebel, C.L., Press, D.M., Kratzer, S.O., Zhao, H., Berrettini, W.H., Buono, R.J., 2004. Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene. Mamm. Genome 15, 239–251. Fonseca, C.G., Green, C.R., Nicholson, L.F., 2002. Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res. 929, 105–116. Gajda, Z., Gyengesi, E., Hermesz, E., Ali, K.S., Szente, M., 2003. Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo. Epilepsia 44, 1596–1600. Gardner-Medwin, A.R., 1983. Analysis of potassium dynamics in mammalian brain tissue. J. Physiol. 335, 393–426. Giaume, C., Koulakoff, A., Roux, L., Holcman, D., Rouach, N., 2010. Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat. Rev. Neurosci. 11, 87–99.

Gigout, S., Louvel, J., Kawasaki, H., D’Antuono, M., Armand, V., Kurcewicz, I., Olivier, A., Laschet, J., Turak, B., Devaux, B., Pumain, R., Avoli, M., 2006. Effects of gap junction blockers on human neocortical synchronization. Neurobiol. Dis. 22, 496–508. Gomez-Gonzalo, M., Losi, G., Chiavegato, A., Zonta, M., Cammarota, M., Brondi, M., Vetri, F., Uva, L., Pozzan, T., de, C.M., Ratto, G.M., Carmignoto, G., 2010. An excitatory loop with astrocytes contributes to drive neurons to seizure threshold. PLoS Biol. 8, e1000352. Gosejacob, D., Dublin, P., Bedner, P., Huttmann, K., Zhang, J., Tress, O., Willecke, K., Pfrieger, F., Steinhauser, C., Theis, M., 2011. Role of astroglial connexin30 in hippocampal gap junction coupling. Glia 59, 511–519. Haj-Yasein, N.N., Jensen, V., Vindedal, G.F., Gundersen, G.A., Klungland, A., Ottersen, O.P., Hvalby, O., Nagelhus, E.A., 2011. Evidence that compromised K(+) spatial)buffering contributes to the epileptogenic effect of mutations in the human kir4.1 gene (KCNJ10. Glia 59, 1635–1642. Halassa, M.M., Haydon, P.G., 2010. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu. Rev. Physiol. 72, 335–355. Hansen, A.J., 1985. Effect of anoxia on ion distribution in the brain. Physiol. Rev. 65, 101–148. Heinemann, U., Lux, H.D., 1977. Ceiling of stimulus induced rises in extracellular potassium concentration in the cerebral cortex of cat. Brain Res. 120, 231–249. Heinemann, U., Gabriel, S., Jauch, R., Schulze, K., Kivi, A., Eilers, A., Kovacs, R., Lehmann, T.N., 2000. Alterations of glial cell function in temporal lobe epilepsy. Epilepsia 41, S185–S189. Heinemann, U., Kaufer, D., Friedman, A., 2012. Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia 60, 1251–1257. Heuser, K., Nagelhus, E.A., Tauboll, E., Indahl, U., Berg, P.R., Lien, S., Nakken, S., Gjerstad, L., Ottersen, O.P., 2010. Variants of the genes encoding AQP4 and Kir4.1 are associated with subgroups of patients with temporal lobe epilepsy. Epilepsy Res. 88, 55–64. Hinterkeuser, S., Schröder, W., Hager, G., Seifert, G., Blümcke, I., Elger, C.E., Schramm, J., Steinhäuser, C., 2000. Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances. Eur. J. Neurosci. 12, 2087–2096. Jahromi, S.S., Wentlandt, K., Piran, S., Carlen, P.L., 2002. Anticonvulsant actions of gap junctional blockers in an in vitro seizure model. J. Neurophysiol. 88, 1893–1902. Jauch, R., Windmuller, O., Lehmann, T.N., Heinemann, U., Gabriel, S., 2002. Effects of barium, furosemide, ouabaine and 4,40 -diisothiocyanatostilbene-2,20 -disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy. Brain Res. 925, 18–27. Khurgel, M., Ivy, G.O., 1996. Astrocytes in kindling: Relevance to epileptogenesis. Epilepsy Res. 26, 163–175. Kivi, A., Lehmann, T.N., Kovacs, R., Eilers, A., Jauch, R., Meencke, H.J., Von Deimling, A., Heinemann, U., Gabriel, S., 2000. Effects of barium on stimulus-induced rises of [K+]o in human epileptic non-sclerotic and sclerotic hippocampal area CA1. Eur. J. Neurosci. 12, 2039–2048. Kofuji, P., Newman, E.A., 2004. Potassium buffering in the central nervous system. Neuroscience 129, 1045–1056. Kofuji, P., Ceelen, P., Zahs, K.R., Surbeck, L.W., Lester, H.A., Newman, E.A., 2000. Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina. J. Neurosci. 20, 5733–5740. Kohling, R., Gladwell, S.J., Bracci, E., Vreugdenhil, M., Jefferys, J.G., 2001. Prolonged epileptiform bursting induced by 0-Mg(2+) in rat hippocampal slices depends on gap junctional coupling. Neuroscience 105, 579–587. Lee, S.H., Magge, S., Spencer, D.D., Sontheimer, H., Cornell-Bell, A.H., 1995. Human epileptic astrocytes exhibit increased gap junction coupling. Glia 15, 195–202. Li, J., Shen, H., Naus, C.C., Zhang, L., Carlen, P.L., 2001. Upregulation of gap junction connexin 32 with epileptiform activity in the isolated mouse hippocampus. Neuroscience 105, 589–598. Loddenkemper, T., Grote, K., Evers, S., Oelerich, M., Stogbauer, F., 2002. Neurological manifestations of the oculodentodigital dysplasia syndrome. J. Neurol. 249, 584–595. Löscher, W., Schmidt, D., 2011. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52, 657–678. Maglione, M., Tress, O., Haas, B., Karram, K., Trotter, J., Willecke, K., Kettenmann, H., 2010. Oligodendrocytes in mouse corpus callosum are coupled via gap junction channels formed by connexin47 and connexin32. Glia 58, 1104–1117. Medina-Ceja, L., Cordero-Romero, A., Morales-Villagran, A., 2008. Antiepileptic effect of carbenoxolone on seizures induced by 4-aminopyridine: a study in the rat hippocampus and entorhinal cortex. Brain Res. 1187, 74–81. Meme, W., Calvo, C.F., Froger, N., Ezan, P., Amigou, E., Koulakoff, A., Giaume, C., 2006. Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. FASEB J. 20, 494–496. Menichella, D.M., Goodenough, D.A., Sirkowski, E., Scherer, S.S., Paul, D.L., 2003. Connexins are critical for normal myelination in the CNS. J. Neurosci. 23, 5963– 5973. Menichella, D.M., Majdan, M., Awatramani, R., Goodenough, D.A., Sirkowski, E., Scherer, S.S., Paul, D.L., 2006. Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J. Neurosci. 26, 10984–10991. Metea, M.R., Kofuji, P., Newman, E.A., 2007. Neurovascular coupling is not mediated by potassium siphoning from glial cells. J. Neurosci. 27, 2468–2471. Mylvaganam, S., Zhang, L., Wu, C., Zhang, Z.J., Samoilova, M., Eubanks, J., Carlen, P.L., Poulter, M.O., 2010. Hippocampal seizures alter the expression of the pannexin and connexin transcriptome. J. Neurochem. 112, 92–102.

P. Bedner, C. Steinhäuser / Neurochemistry International 63 (2013) 682–687 Nagy, J.I., Rash, J.E., 2000. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res. Rev. 32, 29–44. Naus, C.C.G., Bechberger, J.F., Paul, D.L., 1991. Gap junction gene expression in human seizure disorder. Exp. Neurol. 111, 198–203. Nemani, V.M., Binder, D.K., 2005. Emerging role of gap junctions in epilepsy. Histol. Histopathol. 20, 253–259. Neusch, C., Rozengurt, N., Jacobs, R.E., Lester, H.A., Kofuji, P., 2001. Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J. Neurosci. 21, 5429–5438. Newman, E.A., 1995. Glial cell regulation of extracellular potassium. In: Kettenmann, H., Ransom, B.R. (Eds.), Neuroglia. Oxford University Press, New York, pp. 717–731. Newman, E.A., Frambach, D.A., Odette, L.L., 1984. Control of extracellular potassium levels by retinal glial cell K+ siphoning. Science 225, 1174–1175. Olsen, M., Sontheimer, H., 2008. Functional implications for Kir4.1 channels in glial biology: From K+ buffering to cell differentiation. J. Neurochem. 107, 589–601. Orkand, R.K., Nicholls, J.G., Kuffler, S.W., 1966. Effect of nerve impulses on the membrane potential of glial cells in the central nervous system of amphibia. J. Neurophysiol. 29, 788–806. Pannasch, U., Vargova, L., Reingruber, J., Ezan, P., Holcman, D., Giaume, C., Sykova, E., Rouach, N., 2011. Astroglial networks scale synaptic activity and plasticity. Proc. Natl. Acad. Sci. USA. 108, 8467–8472. Paulson, O.B., Newman, E.A., 1987. Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? Science 237, 896–898. Perea, G., Araque, A., 2010. GLIA modulates synaptic transmission. Brain Res. Rev. 63, 93–102. Perez-Velazquez, J.L., Valiante, T.A., Carlen, P.L., 1994. Modulation of gap junctional mechanisms during calcium-free induced field burst activity: a possible role for electrotonic coupling in epileptogenesis. J. Neurosci. 14, 4308–4317. Rana, S., Dringen, R., 2007. Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci. Lett. 415, 45–48. Ransom, B.R., 1996. Do glial gap junctions play a role in extracellular ion homeostasis? In: Spray, D.C., Dermietzel, R. (Eds.), Gap Junctions in the Nervous System. Landes Bioscience, Austin, TX, pp. 159–173. Ransom, C.B., Sontheimer, H., 1995. Biophysical and pharmacological characterization of inwardly rectifying K+ currents in rat spinal cord astrocytes. J. Neurophysiol. 73, 333–346. Ransom, C.B., Ransom, B.R., Sontheimer, H., 2000. Activity-dependent extracellular K+ accumulation in rat optic nerve: the role of glial and axonal Na+ pumps. J. Physiol. (London) 522, 427–442. Rash, J.E., 2010. Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system. Neuroscience 168, 982–1008. Reichold, M., Zdebik, A.A., Lieberer, E., Rapedius, M., Schmidt, K., Bandulik, S., Sterner, C., Tegtmeier, I., Penton, D., Baukrowitz, T., Hulton, S.A., Witzgall, R., Ben-Zeev, B., Howie, A.J., Kleta, R., Bockenhauer, D., Warth, R., 2010. KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. Proc. Natl. Acad. Sci. USA. 107, 14490–14495. Retamal, M.A., Froger, N., Palacios-Prado, N., Ezan, P., Saez, P.J., Saez, J.C., Giaume, C., 2007. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J. Neurosci. 27, 13781–13792. Ross, F.M., Gwyn, P., Spanswick, D., Davies, S.N., 2000. Carbenoxolone depresses spontaneous epileptiform activity in the CA1 region of rat hippocampal slices. Neuroscience 100, 789–796. Rouach, N., Koulakoff, A., Abudara, V., Willecke, K., Giaume, C., 2008. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322, 1551–1555. Saez, J.C., Berthoud, V.M., Branes, M.C., Martinez, A.D., Beyer, E.C., 2003. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 83, 1359–1400. Saez, J.C., Retamal, M.A., Basilio, D., Bukauskas, F.F., Bennett, M.V., 2005. Connexinbased gap junction hemichannels: gating mechanisms. Biochim. Biophys. Acta 1711, 215–224. Samoilova, M., Li, J., Pelletier, M.R., Wentlandt, K., Adamchik, Y., Naus, C.C., Carlen, P.L., 2003. Epileptiform activity in hippocampal slice cultures exposed chronically to bicuculline: increased gap junctional function and expression. J. Neurochem. 86, 687–699. Samoilova, M., Wentlandt, K., Adamchik, Y., Velumian, A.A., Carlen, P.L., 2008. Connexin 43 mimetic peptides inhibit spontaneous epileptiform activity in organotypic hippocampal slice cultures. Exp. Neurol. 210, 762–775. Santiago, M.F., Veliskova, J., Patel, N.K., Lutz, S.E., Caille, D., Charollais, A., Meda, P., Scemes, E., 2011. Targeting pannexin1 improves seizure outcome. PLoS ONE 6, e25178.

687

Scemes, E., Spray, D.C., 2012. Extracellular K(+) and astrocyte signaling via connexin and pannexin channels. Neurochem. Res. 37, 2310–2316. Scemes, E., Spray, D.C., Meda, P., 2009. Connexins, pannexins, innexins: novel roles of ‘‘hemi-channels’’. Pflügers Arch. 457, 1207–1226. Scholl, U.I., Choi, M., Liu, T., Ramaekers, V.T., Hausler, M.G., Grimmer, J., Tobe, S.W., Farhi, A., Nelson-Williams, C., Lifton, R.P., 2009. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc. Natl. Acad. Sci. USA. 106, 5842–5847. Schröder, W., Hinterkeuser, S., Seifert, G., Schramm, J., Jabs, R., Wilkin, G.P., Steinhäuser, C., 2000. Functional and molecular properties of human astrocytes in acute hippocampal slices obtained from patients with temporal lobe epilepsy. Epilepsia 41, S181–S184. Seifert, G., Schilling, K., Steinhäuser, C., 2006. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 7, 194–206. Seifert, G., Hüttmann, K., Binder, D.K., Hartmann, C., Wyczynski, A., Neusch, C., Steinhäuser, C., 2009. Analysis of astroglial K+ channel expression in the developing hippocampus reveals a predominant role of the Kir4.1 subunit. J. Neurosci. 29, 7474–7488. Seifert, G., Carmignoto, G., Steinhäuser, C., 2010. Astrocyte dysfunction in epilepsy. Brain Res. Rev. 63, 212–221. Sicca, F., Imbrici, P., D’Adamo, M.C., Moro, F., Bonatti, F., Brovedani, P., Grottesi, A., Guerrini, R., Masi, G., Santorelli, F.M., Pessia, M., 2011. Autism with seizures and intellectual disability: Possible causative role of gain-of-function of the inwardly-rectifying K(+) channel Kir4.1. Neurobiol. Dis. 43, 239–247. Simonato, M., Loscher, W., Cole, A.J., Dudek, F.E., Engel Jr., J., Kaminski, R.M., Loeb, J.A., Scharfman, H., Staley, K.J., Velisek, L., Klitgaard, H., 2012. Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design. Epilepsia 53, 1860–1867. Söhl, G., Güldenagel, M., Beck, H., Teubner, B., Traub, O., Gutierrez, R., Heinemann, U., Willecke, K., 2000. Expression of connexin genes in hippocampus of kainatetreated and kindled rats under conditions of experimental epilepsy. Mol. Brain Res. 83, 44–51. Somjen, G.G., 2001. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev. 81, 1065–1096. Suadicani, S.O., Iglesias, R., Wang, J., Dahl, G., Spray, D.C., Scemes, E., 2012. ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes. Glia 60, 1106–1116. Szente, M., Gajda, Z., Said, A.K., Hermesz, E., 2002. Involvement of electrical coupling in the in vivo ictal epileptiform activity induced by 4-aminopyridine in the neocortex. Neuroscience 115, 1067–1078. Takahashi, D.K., Vargas, J.R., Wilcox, K.S., 2010. Increased coupling and altered glutamate transport currents in astrocytes following kainic-acid-induced status epilepticus. Neurobiol. Dis. 40, 573–585. Theis, M., Giaume, C., 2012. Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res. 1487, 88–98. Tress, O., Maglione, M., May, D., Pivneva, T., Richter, N., Seyfarth, J., Binder, S., Zlomuzica, A., Seifert, G., Theis, M., Dere, E., Kettenmann, H., Willecke, K., 2012. Panglial gap junctional communication is essential for maintenance of myelin in the CNS. J. Neurosci. 32, 7499–7518. Verkhratsky, A., Steinhäuser, C., 2000. Ion channels in glial cells. Brain Res. Rev. 32, 380–412. Vezzani, A., Friedman, A., Dingledine, R.J., 2012. in press. The role of inflammation in epileptogenesis. Neuropharmacology. Voss, L.J., Jacobson, G., Sleigh, J.W., Steyn-Ross, A., Steyn-Ross, M., 2009. Excitatory effects of gap junction blockers on cerebral cortex seizure-like activity in rats and mice. Epilepsia 50, 1971–1978. Wallraff, A., Kohling, R., Heinemann, U., Theis, M., Willecke, K., Steinhäuser, C., 2006. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J. Neurosci. 26, 5438–5447. Walz, W., 2000. Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int. 36, 291–300. Williams, D.M., Lopes, C.M., Rosenhouse-Dantsker, A., Connelly, H.L., Matavel, A., Uchi, J., McBeath, E., Gray, D.A., 2010. Molecular basis of decreased Kir4.1 function in SeSAME/EAST syndrome. J. Am. Soc. Nephrol. 21, 2117–2129. Xu, L., Zeng, L.H., Wong, M., 2009. Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex. Neurobiol. Dis. 34, 291–299. Ye, Z.C., Wyeth, M.S., Baltan-Tekkok, S., Ransom, B.R., 2003. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 23, 3588–3596. Yoon, J.J., Green, C.R., O’Carroll, S.J., Nicholson, L.F., 2010. Dose-dependent protective effect of connexin43 mimetic peptide against neurodegeneration in an ex vivo model of epileptiform lesion. Epilepsy Res. 92, 153–162.